These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9322880)

  • 1. Pharmaceutical properties of paclitaxel and their effects on preparation and administration.
    Trissel LA
    Pharmacotherapy; 1997; 17(5 Pt 2):133S-139S. PubMed ID: 9322880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
    Trissel LA; Xu Q; Kwan J; Martinez JF
    Am J Hosp Pharm; 1994 Nov; 51(22):2804-10. PubMed ID: 7856604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A; van Tellingen O; Nooijen WJ; Beijnen JH
    Cancer Res; 1996 May; 56(9):2112-5. PubMed ID: 8616858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles.
    Kim SC; Yoon HJ; Lee JW; Yu J; Park ES; Chi SC
    Int J Pharm; 2005 Apr; 293(1-2):303-10. PubMed ID: 15778068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
    Malingré MM; Schellens JH; Van Tellingen O; Ouwehand M; Bardelmeijer HA; Rosing H; Koopman FJ; Schot ME; Ten Bokkel Huinink WW; Beijnen JH
    Br J Cancer; 2001 Nov; 85(10):1472-7. PubMed ID: 11720431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding carcinogen exposure with intraperitoneal paclitaxel.
    Stuart OA; Knight C; Sugarbaker PH
    Oncol Nurs Forum; 2005 Jan; 32(1):44-8. PubMed ID: 15660142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application.
    Treleano A; Wolz G; Brandsch R; Welle F
    Int J Pharm; 2009 Mar; 369(1-2):30-7. PubMed ID: 19027840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of paclitaxel (Taxol) administration, stability, and compatibility issues.
    Boyle DA; Goldspiel BR
    Clin J Oncol Nurs; 1998 Oct; 2(4):141-5. PubMed ID: 10232160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
    Meerum Terwogt JM; Malingré MM; Beijnen JH; ten Bokkel Huinink WW; Rosing H; Koopman FJ; van Tellingen O; Swart M; Schellens JH
    Clin Cancer Res; 1999 Nov; 5(11):3379-84. PubMed ID: 10589748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
    Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical stability of paclitaxel infusions in different container types.
    Donyai P; Sewell GJ
    J Oncol Pharm Pract; 2006 Dec; 12(4):211-22. PubMed ID: 17156593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of paclitaxel-containing liposomes.
    Holvoet C; Vander Heyden Y; Lories G; Plaizier-Vercammen J
    Pharmazie; 2007 Feb; 62(2):126-32. PubMed ID: 17341033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seventy-two-hour stability of Taxol in 5% dextrose or 0.9% sodium chloride in Viaflo, Freeflex, Ecoflac and Macoflex N non-PVC bags.
    Pourroy B; Botta C; Solas C; Lacarelle B; Braguer D
    J Clin Pharm Ther; 2005 Oct; 30(5):455-8. PubMed ID: 16164492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation.
    Zhang JA; Anyarambhatla G; Ma L; Ugwu S; Xuan T; Sardone T; Ahmad I
    Eur J Pharm Biopharm; 2005 Jan; 59(1):177-87. PubMed ID: 15567316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
    Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers.
    Kambia NK; Dine T; Dupin-Spriet T; Gressier B; Luyckx M; Goudaliez F; Brunet C
    J Pharm Biomed Anal; 2005 Feb; 37(2):259-64. PubMed ID: 15708665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer.
    O'Connor TL; Kossoff E
    Pharmacotherapy; 2009 Aug; 29(8):993-6. PubMed ID: 19637953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).
    Sparreboom A; Scripture CD; Trieu V; Williams PJ; De T; Yang A; Beals B; Figg WD; Hawkins M; Desai N
    Clin Cancer Res; 2005 Jun; 11(11):4136-43. PubMed ID: 15930349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.
    Bardelmeijer HA; Ouwehand M; Malingré MM; Schellens J; Beijnen JH; van Tellingen O
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):119-25. PubMed ID: 11862425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.